Shandong Boan Biotechnology Co., Ltd. (HKG:6955)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
6.66
-0.17 (-2.49%)
At close: May 7, 2026
Market Cap4.14B -5.5%
Revenue (ttm)873.36M +8.1%
Net Income7.95M -90.2%
EPS0.01 -90.9%
Shares Out622.33M
PE Ratio521.36
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume2,447,800
Average Volume3,630,480
Open6.91
Previous Close6.83
Day's Range6.66 - 6.91
52-Week Range6.12 - 19.90
Beta0.05
RSI43.00
Earnings DateMay 27, 2026

About HKG:6955

Shandong Boan Biotechnology Co., Ltd., a biopharmaceutical company, develops, manufactures, and markets biologics in Mainland China. The company offers Boyounuo (BA1101), an anti-VEGF humanized monoclonal antibody injection for mCRC, advanced metastatic or recurrent non-small cell lung cancer, recurrent glioblastoma, epithelial ovarian, fallopian tube, primary peritoneal cancer, cervical cancer, and hepatocellular carcinoma indications; Boyoubei (BA6101), a human immunoglobulin G2 monoclonal antibody of the RANK ligand for the treatment of post... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2013
Employees 714
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 6955
Full Company Profile

Financial Performance

In 2025, HKG:6955's revenue was 784.82 million, an increase of 8.06% compared to the previous year's 726.32 million. Earnings were 7.14 million, a decrease of -90.24%.

Financial numbers in CNY Financial Statements